MS Pharma to expand manufacturing facilities with $30 million investment from EBRD

Specifications:

Name:

MS Pharma to expand manufacturing facilities with $30 million investment from EBRD

Location:

Jordan

Company:

MS Pharma

Estimated Cost:

$30 million

Source:

zawya.com

Introduction:

Jordan's MS Pharma received $30 million from European Bank for Reconstruction and Development (EBRD) for the production of new generic pharmaceutical products.

Features:

This investment will help the company to upgrade and expand its manufacturing facilities, increase its capacity and produce specialised products for chronic illnesses such as cancer, or cardiovascular, central nervous system and respiratory diseases and also it will contribute to the commercialisation of these products and improve access to the latest generation of pharmaceutical products in the region.